What is the prevalence of Hemicrania Continua?

Hemicrania continua is a rare, strictly unilateral primary headache disorder characterized by continuous pain with superimposed exacerbations. While exact global prevalence remains unknown due to frequent misdiagnosis, it is estimated to affect approximately 1 in 20,000 to 50,000 people, though these figures are likely underestimates.

Is Hemicrania continua considered a rare disease?

Yes, Hemicrania continua is classified as a rare condition. Because the hallmark of the disease is a dramatic, absolute response to the medication indomethacin, many patients are misdiagnosed for years with other primary headaches like migraine or cluster headache. This diagnostic delay significantly complicates efforts to establish precise epidemiological data regarding Hemicrania continua.

What are the demographic patterns of Hemicrania continua?

Clinical literature indicates specific trends in how Hemicrania continua presents across populations:

• Gender Distribution: The condition shows a clear female predominance, with studies suggesting a female-to-male ratio of approximately 2:1.


• Age of Onset: While Hemicrania continua can occur at any age, the typical age of onset is during adulthood, most commonly between the ages of 20 and 40.


• Geographic/Ethnic Variation: There is currently no robust data suggesting that Hemicrania continua is more prevalent in any specific geographic region or ethnic group.

Why is accurate data for Hemicrania continua limited?

The primary challenge in mapping Hemicrania continua is the "indomethacin-responsive" criterion. Because many clinicians do not consider this diagnosis unless a patient has already failed multiple other treatments, the condition is significantly under-reported in medical literature. At DiseaseMaps.org, we have seen 86 people with Hemicrania continua join our community, providing a real-world perspective that helps supplement clinical data by highlighting the lived experience of diagnostic journeys and symptom management.

Next steps

• Consult a neurologist or headache specialist to discuss an indomethacin trial, which is the gold-standard diagnostic test for Hemicrania continua.


• Maintain a detailed headache diary to track the constant pain levels versus the intensity of exacerbations.


• Join the DiseaseMaps.org community to connect with others who understand the diagnostic hurdles associated with this condition.

Medical disclaimer: This information is for educational purposes only and does not substitute professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Hemicrania continua.


• Orphanet: Hemicrania continua (ORPHA:3908).


• International Headache Society: The International Classification of Headache Disorders (ICHD-3).


• American Migraine Foundation: Understanding Hemicrania Continua.